What We Learned at SCDM 2025—and How to Act on It
Summary SCDM 2025 marked a turning point for clinical data management. This recap breaks down six lessons shaping the future...
From Dollars to Debate: Why Clinical Trials are at a Crossroad
At the risk of a grievous understatement, 2025 has brought significant shifts in US federal funding priorities Clinical research, long...
OpenClinica’s Most Read Blogs of 2025
At OpenClinica, we publish a new blog most weeks. One of our favorite things to do is a mid-year checkup....
EHR-to-EDC: The Way of The Future Or a Pipe Dream?
Without a doubt, I wholeheartedly believe EHR-to-EDC integration is the future of clinical trials. There are at least 10 reasons...
Leading the Way: OpenClinica EDC Earns Major Recognition
ICYMI, the Everest Group named the OpenClinica EDC the leading Major Contender in the 2024 Life Sciences Electronic Data Capture...
OpenClinica Customers: In Their Words
As CEO and Co-Founder, I am firmly committed to the OpenClinica user-driven experience where we enhance user experience by directly...
Connecting Global Minds to Shape the Future of Clinical Trials
As OpenClinica’s Co-Founder and COO, I had the pleasure of serving as the host for OC24, our annual global conference...
Eight Ways Medical Device Clinical Trials Differ from Drug Trials
About two million medical devices in 7,000+ categories are on the market. According to the Food and Drug Administration (FDA),...
Registry Studies Are Unique: 8 Distinct Features
The primary purpose of registry studies has traditionally been to collect data to better understand long-term trends in specific populations....
Letter from our CEO
Recently, a few of us at OpenClinica received an email from a long-time customer who was leaving her organization for...